|
well, I voted no on 71, but yes, I'll be paying for it. For those that don't know, the line between "public" and "private" funding of basic and applied research is so blurred it can barely be seen anymore. During my postdoc days at UCSF, almost every single faculty member in the biochem/biophys and pharmaceutical chem departments was involved in a biotech startup. And that was 10 years ago...it has only gotten more intertwined. In fact we are currently working hard to come up with new institutional models to better deal with interdisciplinary/collaborative research that is funded through combinations of industry/gov/private money.
So have court challenges to 71 been filed yet? I would imagine that if it is so obviously a sham to bail out a single company, someone would feel compelled to litigate.
|